Showing results (201-210 of 566) with videos related to

Sort By:
Pageof 57
Arthritis and Rheumatism|December 30, 2006
Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosusMartin Aringer, Günter Steiner, Winfried B Graninger, et al.
RMD Open|December 24, 2024
Rationale for phosphodiesterase-4 inhibition as a treatment strategy for interstitial lung diseases associated with rheumatic diseasesMartin Aringer, Oliver Distler, Anna-Maria Hoffmann-Vold, et al.
Annals of the New York Academy of Sciences|July 13, 2004
Engineering anticancer T cells for extended functional longevityGraham Pawelec, Erminia Mariani, Julie McLeod, et al.
Wiener Klinische Wochenschrift|January 5, 2005
Immunoadsorption (IAS) as a rescue therapy in SLE: considerations on safety and efficacyGeorg H Stummvoll, Martin Aringer, Martin Jansen, et al.
Advances in Therapy|December 14, 2021
The Economic Burden of Thromboembolic Events Among Patients with Immune-Mediated DiseasesJuliana Setyawan, Emma Billmyer, Fan Mu, et al.
The Journal of Rheumatology|November 16, 2020
Relation Between Fatigue and ACR Response in Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitor Therapy: A Population-based Cohort StudyTanja Schjødt Jørgensen, Marie Skougaard, Rebekka Lund Hansen, et al.
Arthritis and Rheumatism|October 31, 2009
Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritisArthur Kavanaugh, Josef S Smolen, Paul Emery, et al.
The Lancet. Rheumatology|June 22, 2025
Sarilumab in relapsing polymyalgia rheumatica: patient-reported outcomes from a phase 3, double-blind, randomised controlled trialVibeke Strand, Jerome Msihid, Jennifer Sloane, et al.
Advances in Therapy|December 8, 2021
Risk of Thromboembolic Events and Associated Healthcare Costs in Patients with Inflammatory Bowel DiseaseJuliana Setyawan, Fan Mu, Miriam L Zichlin, et al.
RMD Open|November 10, 2017
Discordant patient-physician assessments of disease activity and its persistence adversely impact quality of life and work productivity in US Hispanics with rheumatoid arthritisGeorge A Karpouzas, Sera N Ramadan, Chelsie E Cost, et al.
Pageof 57